Revealing Pretargeting for 177Lu/225Ac Dual-Isotope Therapy of Colorectal Cancer

Time: 12:45 pm
day: Day One Discovery AM


  • Pretargeting as a suitable approach for efficient and controlled tandem-radiotherapy
  • Confirming co-localization of 225Ac- and 177Lu-labeled radiohaptens with autoradiography using iQID
  • Pretargeted 177Lu/225Ac dual-isotope therapy can be safely administered at potentially curative doses (62.9 GBq/kg 177Lu + 2 MBq/kg 225Ac) in mice